EUDRAGIT® Masterclass Series | Session 5

Enteric polymers and GI targeting

November 22, 2023 | 4:00 p.m. (CET) / 10:00 a.m. (EST)
Outline

This webinar will explore innovative formulation approaches for targeted oral drug delivery, with a focus on EUDRAGIT® enteric polymers and their use to achieve gastrointestinal (GI) targeting. EUDRAGIT® polymers offer a range of properties that make them ideal for creating enteric coatings that can withstand the acidic environment of the stomach and release their payload in the more alkaline environment of the intestines. We will discuss the important factors in the selection and formulation of EUDRAGIT® polymers and their use in developing effective GI-targeted formulations. Selected case studies from in vivo evaluations will be presented. In addition, we will discuss the use of precoated capsules (EUDRACAP®) as a means of simplifying the formulation process and improving drug delivery. EUDRATEC® technologies will be briefly presented to complement the portfolio of enteric solutions for the pharmaceutical market.

The information presented will be useful for anyone working in the pharmaceutical industry seeking to optimize the oral delivery of their drugs, particularly those requiring GI targeting.
Key learnings for participants

  • An overview of EUDRAGIT® enteric polymers for GI targetin
  • Efficacy of enteric EUDRAGIT® formulations in vivo
  • Benefits of EUDRACAP® precoated capsules
  • Selected technologies to further improve GI targeting

Experts featured this session

  • Dr. Miriam Robota
    Head of Formulation Services
    Evonik Health Care

    Dr. Miriam Robota is head of Formulation Services at Evonik Health Care in Darmstadt. In this role, she is responsible for the business development and implementation of formulation development service projects with a focus on pharmaceutical solid oral dosage forms. She also gives technical consultation and trainings on the Evonik Health Care product portfolio. Over her career she has worked in several roles within Evonik such as heading the formulation development laboratory, application technology laboratory and production of clinical sample manufacturing for clinical studies phase I and II. Miriam has substantial experience in the application of EUDRAGIT® within the formulation development of solid oral dosage forms with immediate and modified release.

    Miriam is regular speaker at workshops and international conferences and is an author of several publications.

Fill out the form to register for your preferred webinar session:

More about other webinars in this series

EUDRAGIT® Masterclass Series | Session 6

Sustained release formulations

December 6, 2023 | 4:00 p.m. (CET) / 10:00 a.m. (EST) 

The use of either multiparticulate or matrix formulations containing EUDRAGIT® polymers allows for the controlled release of active pharmaceutical ingredients, resulting in improved drug efficacy and reduced dosing frequency. In addition, we will discuss the incorporation of Chematic® cleaners into manufacturing processes to simplify equipment cleaning, resulting in reduced downtime and increased productivity. Through case studies and examples, this presentation highlights the benefits of using EUDRAGIT® polymers to maximize the potential of oral solid dosage forms.

Register

Session 3 | June 15, 4:00 p.m. CEST / 10:00 a.m. EDT

Purity is paramount: Customized approaches for superior quality control at Evonik

The quality of lipids in a lipid nanoparticle (LNP) assembly is critically important to the functionality of mRNA-based therapeutics. Any unwanted chemical reaction between the lipids and the labile mRNA will affect the product stability and efficacy of the vaccine or therapeutic. In this webinar, our expert describes Evonik’s approach to superior quality control lipid analytics. In two case studies, this webinar outlines the role of novel multivariate models in speeding up timelines and increasing knowledge, and demonstrates that Evonik lipids show a consistently negligible level of N-oxide and aldehyde impurities, enabling safe usage in LNPs.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register